Rasmus Leistner - Concepedia

Author

Rasmus Leistner

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Leistner, Rasmus, R Leistner, R. LEISTNER, R. Leistner, Rasmus Leistner

112

Publications

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Robert Koch Institute Freie Universität Berlin Humboldt-Universität zu Berlin Berlin Institute of Health at Charité - Universitätsmedizin Berlin

About

Rasmus Leistner is an author at Charité - Universitätsmedizin Berlin specializing in medicine, infection control, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	477
2	Health Sciences	3	3	68
3	Engineering	1	1	16
4	Public Health	1	1	65
5	Biomedical Engineering	1	1	16

Rasmus Leistner

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Nosocomial Infections in Very Low Birthweight Infants in Germany: Current Data from the National Surveillance System NEO-KISS Rasmus Leistner, Brar Piening, Petra Gastmeier, Klinische Pädiatrie	2013	119
Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany Michael Pietsch, Christoph Eller, Constanze Wendt, Veterinary Microbiology Molecular CharacterisationAntimicrobial SusceptibilityAntimicrobial Resistance GeneAntibioticsEscherichia Coli Isolates	2015	106
The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum -lactamase-producing Enterobacteriaceae (ESBL-E) Luisa A. Denkel, F. Schwab, Axel Kola, Journal of Antimicrobial Chemotherapy	2014	100
The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections Tobias Siegfried Kramer, Cornelius Remschmidt, S. Werner, Antimicrobial Resistance and Infection Control	2018	81
Risk Factors Associated with the Community-Acquired Colonization of Extended-Spectrum Beta-Lactamase (ESBL) Positive Escherichia Coli. An Exploratory Case-Control Study Rasmus Leistner, Elisabeth Meyer, Petra Gastmeier, PLoS ONE	2013	74
Prolonged outbreak of clonal MDR Pseudomonas aeruginosa on an intensive care unit: contaminated sinks and contamination of ultra-filtrate bags as possible route of transmission? Florian Salm, Maria Deja, Petra Gastmeier, Antimicrobial Resistance and Infection Control	2016	69
Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort Rasmus Leistner, Stephan Gürntke, Christian Sakellariou, Infection E. ColiAntibioticsKlebsiella PneumoniaeHealthcare-associated InfectionK. Pneumoniae	2014	65
Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): a matched prospective cohort study Rasmus Leistner, E. Hirsemann, A. Bloch, Infection Venous DiseaseHealthcare-associated InfectionPatient SafetyClinical EpidemiologyHospital Epidemiology	2013	65
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients Rasmus Leistner, Lisa Schroeter, Thomas C. Adam, Critical Care	2022	63
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae Luisa A. Denkel, Friederike Maechler, F. Schwab, Clinical Microbiology and Infection Rectal ColonizationMicrobial DiseaseEsbl-producing Escherichia ColiAntibioticsMedicine	2019	55

Page 1